PULIKE BIOLOGICAL ENGINEERING, INC. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.2 CNY | -3.86% |
|
-2.11% | -24.06% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Pulike Biological Engineering. Inc is principally engaged in the research, development, production and distribution of veterinary biological products and chemical medicines. The Company's veterinary biological products include vaccine and antibody, applied in the prevention and controlling of infection to epidemic disease for poultry and livestock. Its veterinary chemical medicines are mainly used in the treatment of epidemic diseases of poultry and livestock.
Sector
Pharmaceuticals
Calendar
2024-08-21
- Q2 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
6
Last Close Price
17.2
CNY
Average target price
19.98
CNY
Spread / Average Target
+16.16%
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -24.06% | 805M | |
| -19.73% | 72.39B | |
| -11.01% | 6.54B | |
| +15.88% | 3.43B | |
| -0.68% | 1.4B | |
| -17.27% | 1.34B | |
| -2.73% | 1.26B | |
| -28.16% | 1.2B | |
| -14.67% | 1.12B | |
| -5.37% | 990M |
- Stock Market
- Equities
- 603566 Stock
- News Pulike Biological Engineering, Inc.
- Pulike Biological's Vaccine for Feline Respiratory Diseases Passes Chinese Emergency Evaluation
